🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

148,36 USD

Máx. histórico

156,45

69 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,17%

Rango 52 semanas

82,01 – 156,92

Variación hoy

-0,78%

Cierre anterior

149,52

Rango de hoy

147,12 – 150,25

Volumen hoy

9.050.917

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,42%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
149,86 (puede no estar actualizado)
Dividend yield
2,27% (puede no estar actualizado)
Precio objetivo analistas
159,91 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 23 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,29%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/04/2025 80,02 80,02 78,36 79,17 -0,01% 2,07% 15.796.700
11/04/2025 77,87 79,44 76,35 79,18 +2,10% 3,97% 16.194.400
10/04/2025 80,61 81,12 75,96 77,55 -5,32% 6,40% 19.466.900
09/04/2025 76,76 81,99 76,00 81,91 +3,75% 7,80% 22.928.300
08/04/2025 83,21 83,27 77,54 78,95 -2,75% 6,89% 20.571.600
07/04/2025 81,01 83,21 79,30 81,18 -0,36% 4,83% 26.582.000
04/04/2025 86,12 86,27 81,08 81,47 -5,70% 6,03% 22.965.700
03/04/2025 88,73 88,90 86,26 86,39 -0,24% 2,98% 12.684.100
02/04/2025 86,88 87,07 85,32 86,60 -0,60% 2,01% 10.590.800
01/04/2025 89,75 89,75 86,61 87,12 -2,94% 3,50% 13.922.100
31/03/2025 89,25 90,27 88,37 89,76 +0,59% 2,13% 15.003.000
28/03/2025 88,20 90,14 87,67 89,23 +1,86% 2,80% 12.393.500
27/03/2025 88,50 88,56 87,38 87,60 -0,58% 1,33% 12.931.900
26/03/2025 88,24 89,32 87,31 88,11 +0,27% 2,28% 13.808.800
25/03/2025 92,31 92,31 87,08 87,87 -4,81% 5,67% 20.640.200
24/03/2025 92,90 93,11 91,56 92,31 -0,86% 1,67% 16.950.100
21/03/2025 94,58 94,68 93,07 93,11 -1,71% 1,70% 68.435.800
20/03/2025 94,00 95,16 93,68 94,73 +0,76% 1,57% 12.970.200
19/03/2025 95,25 95,43 93,64 94,02 -0,74% 1,88% 11.355.900
18/03/2025 95,23 95,41 93,84 94,72 -0,07% 1,65% 8.670.100
17/03/2025 93,65 95,30 93,08 94,79 +0,23% 2,37% 12.237.900
14/03/2025 94,28 94,88 93,45 94,57 -0,15% 1,52% 12.681.100
13/03/2025 93,40 96,34 93,40 94,71 +1,46% 3,15% 16.570.100
12/03/2025 94,07 94,40 92,86 93,35 -1,46% 1,64% 11.896.000
11/03/2025 94,98 95,38 93,58 94,73 -0,53% 1,90% 21.734.800
10/03/2025 94,69 97,00 94,69 95,23 +0,61% 2,44% 20.897.600
07/03/2025 94,26 97,37 93,85 94,65 +0,69% 3,73% 24.100.900
06/03/2025 93,13 94,05 91,78 94,00 +0,87% 2,44% 11.300.200
05/03/2025 91,08 93,45 90,50 93,19 +0,68% 3,24% 13.117.100
04/03/2025 93,57 95,36 92,32 92,56 -0,63% 3,25% 15.073.000